Optimization of the entrapment of bacterial cell envelope extracts into microparticles for vaccine delivery

References

• Acouturier J, Dupuis L, Ganne V. Adjuvants designed for veterinary and human vaccines. Vaccine 2001; 19: 2666–2672
   PubMedGoogle Scholar
• Aguiar MMG, Rodrigues JM, Cunha AS. Encapsulation of insulin-cyclodextrin complex in PLGA microspheres: a new approach for prolonged pulmonary insulin delivery. Journal of Microencapsulation 2004; 21: 553–564
   PubMed Web of Science ®Google Scholar
• Alonso MJ, Gupta RK, Min C, Siber GR, Langer R. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine 1994; 12: 299–306
   PubMed Web of Science ®Google Scholar
• Bardenstein S, Mandelboim M, Ficht TA, Baum M, Banai M. Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene. Journal of Clinical Microbiology 2002; 40: 1475–1480
   PubMedGoogle Scholar
• Benoit MA, Baras B, Gillard J. Preparation and characterization of protein-loaded poly(ϵ-caprolactone) microparticles for oral vaccine delivery. International Journal of Pharmaceutics 1999; 184: 73–84
   PubMed Web of Science ®Google Scholar
• Berkland C, Kipper MJ, Narasimhan B, Kyekyoon K, Pack DW. Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres. Journal of Controlled Release 2004; 94: 129–141
   PubMed Web of Science ®Google Scholar
• Berkland C, Kyekyoon K, Pack DW. PLG microsphere size controls drug release rate through several competing factors. Pharmaceutical Research 2003; 20: 1055–1062
   PubMed Web of Science ®Google Scholar
• Blasco JM, Díaz R. Brucella melitensis Rev1 vaccine as a cause of human brucellosis. Lancet 1993; 342: 805
   PubMedGoogle Scholar
• Coombes AGA, Yeh MK, Lavelle EC, Davis SS. The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in-oil-in-water method. Journal of Controlled Release 1998; 52: 311–320
   PubMed Web of Science ®Google Scholar
• Duchêne D, Ponchel G, Wouessidjewe D. Cyclodextrins in targeting: application to nanoparticles. Advanced Drug Delivery Reviews 1999; 36: 29–40
   PubMed Web of Science ®Google Scholar
• Elberg SS, Faunce K. Immunization against Brucella infection VI. Immunity conferred on goats by nondependent mutant from a streptomycin-dependent mutant strain of Brucella melitensis. Journal of Bacteriology 1957; 73: 211–217
   PubMedGoogle Scholar
• Gamazo C, Winter AJ, Moriyón I, Riezu-Boj JI, Blasco JM, Díaz R. Comparative analysis of proteins extracted by hot saline or release spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis. Infection and Immunity 1989; 57: 1419–1426
   PubMedGoogle Scholar
• Gander B, Johansen P, Nam-Trân H, Merckle HP. Thermodynamic approach to protein microencapsulation into poly(D,L-lactide) by spray drying. International Journal of Pharmaceutics 1996; 129: 51–61
   Google Scholar
• García del Barrio G, Hendry J, Renedo MJ, Irache JM, Novo FJ. In vivo sustained release of adenoviral vectors from poly(D,L-lactic-co-glycolic) acid microparticles prepared by TROMS. Journal of Controlled Release 2004; 94: 229–235
   PubMedGoogle Scholar
• García del Barrio G, Novo FJ, Irache JM. Loading of plasmid DNA into PLGA microparticles using TROMS (Total Recirculation One-Machine System): evaluation of its integrity and controlled release properties. Journal of Controlled Release 2003; 86: 123–130
   PubMed Web of Science ®Google Scholar
• Jiménez de Bagüés MP, Marín CM, Barberán M, Blasco JM. Responses of ewe to B. melitensis Rev1 vaccine administered by subcutaneous or conjuntival routes at different stages of pregnancy. Annual Rechearche of Veterinary 1989; 20: 205–213
   PubMedGoogle Scholar
• Katakam M, Banga AK. Aggregation of insulin and its prevention by carbohydrate excipients. Journal of Pharmaceutical Science 1995; 49: 160–165
   Google Scholar
• Kissel T, Hilbert AK, Koneberg R, Bittner B. Microencapsulation of antigens for parenteral vaccine delivery system. Antigen delivery system: immunological and technological issues, B Gander, HP Merkle, G Corradin. The Gordon and Breach Publishng Group, Amsterdam 1997; 159–190
   Google Scholar
• Lindenstruth K, Müller BW. W/O/W multiple emulsions with diclofenac sodium. European Journal of Pharmaceutics and Biopharmaceutics 2004; 58: 621–627
   PubMed Web of Science ®Google Scholar
• Morlock M, Koll H, Winter G, Kissel T. Microencapsulation of rh-erythropoietin, using biodegradable poly(D,L-lactide-co-glycolide): protein stability and the effects of stabilizing excipients. European Journal of Pharmaceutics and Biopharmaceutics 1997; 43: 29–36
   Web of Science ®Google Scholar
• Murillo M, Gamazo C, Irache JM, Goñi MM. Polyester microparticles as a vaccine delivery system for brucellosis: influence of the polymer on release, phagocytosis and toxicity. Journal of Drug Targeting 2002a; 10: 211–219
   PubMed Web of Science ®Google Scholar
• Murillo M, Goñi MM, Irache JM, Arangoa MA, Blasco JM, Gamazo C. Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens. Journal of Controlled Release 2002b; 85: 237–246
   PubMed Web of Science ®Google Scholar
• Murillo M, Grilló MJ, Reñé J, Marín CM, Barberán M, Goñi MM, Blasco JM, Gamazo C. A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice. Vaccine 2001b; 19: 4099–4106
   PubMed Web of Science ®Google Scholar
• Murillo M, Irache JM, Estevan M, Goñi MM, Blasco JM, Gamazo C. Influence of the co-encapsulation of different excipients on the properties of polyester microparticle-based vaccine against brucellosis. International Journal of Pharmaceutics 2004; 271: 125–135
   PubMed Web of Science ®Google Scholar
• O’Donnell PB, McGinity JW. Preparation of microspheres by the solvent evaporation technique. Advanced Drug Delivery Reviews 1997; 28: 25–42
   PubMed Web of Science ®Google Scholar
• Osborn MJ. Studies on the Gram-negative cell-wall. I. Evidence for the role of 2-keto-3-deoxy-octonate in the lipopolysaccharide of Salmonella typhimurium. Proceedings of the National Academy of Sciences (USA) 1963; 50: 499–506
   PubMedGoogle Scholar
• Riezu-Boj JI, Moriyón I, Blasco JM, Marín CM, Díaz R. Comparison of lipopolysaccharide and outer membrane protein-lipopolysaccharide extracts in an enzime-linked immunosorbent assay for the diagnosis of Brucella ovis infection. Journal of Clininal Microbiology 1986; 23: 938–942
   PubMed Web of Science ®Google Scholar
• Sah H. Stabilization of proteins against methylene chloride/water interphase-induced denaturation and aggregation. Journal of Controlled Release 1999; 58: 143–151
   PubMed Web of Science ®Google Scholar
• Schwendeman SP, Tobio M, Joworowicz M, Alonso MJ, Langer R. New strategies for the microencapsulation of tetanus vaccine. Journal of Microencapsulation 1998; 15: 299–318
   PubMed Web of Science ®Google Scholar
• Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Analitical Biochemestry 1985; 150: 76–85
   PubMed Web of Science ®Google Scholar
• Yeh MK, Liu YT, Chen JL, Chiang CH. Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles. Journal of Controlled Release 2002; 82: 237–247
   PubMed Web of Science ®Google Scholar